Buckingham Capital Management, Inc. Amgen Inc Transaction History
Buckingham Capital Management, Inc.
- $815 Million
- Q1 2024
A detailed history of Buckingham Capital Management, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Buckingham Capital Management, Inc. holds 750 shares of AMGN stock, worth $241,252. This represents 0.03% of its overall portfolio holdings.
Number of Shares
750
Previous 958
21.71%
Holding current value
$241,252
Previous $275,000
22.55%
% of portfolio
0.03%
Previous 0.04%
Shares
17 transactions
Others Institutions Holding AMGN
# of Institutions
2,939Shares Held
401MCall Options Held
6.59MPut Options Held
6.6M-
Vanguard Group Inc Valley Forge, PA52.1MShares$16.8 Billion0.3% of portfolio
-
Black Rock Inc. New York, NY48MShares$15.4 Billion0.32% of portfolio
-
State Street Corp Boston, MA29.1MShares$9.37 Billion0.38% of portfolio
-
Primecap Management CO Pasadena, CA14.6MShares$4.7 Billion3.15% of portfolio
-
Morgan Stanley New York, NY14MShares$4.49 Billion0.32% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $172B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...